Your browser doesn't support javascript.
loading
Should Health Systems Share Genetic Findings With At-Risk Relatives When the Proband Is Deceased? Interviews With Individuals Diagnosed With Lynch Syndrome.
Hunter, Jessica Ezzell; Schneider, Jennifer L; Firemark, Alison J; Davis, James V; Gille, Sara; Pawloski, Pamala A; Liang, Su-Ying; Schlieder, Victoria; Rahm, Alanna Kulchak.
Afiliação
  • Hunter JE; Genomics, Ethics, and Translational Research Program, RTI International, Research Triangle Park, NC.
  • Schneider JL; Kaiser Permanente Center for Health Research, Portland, OR.
  • Firemark AJ; Kaiser Permanente Center for Health Research, Portland, OR.
  • Davis JV; Kaiser Permanente Center for Health Research, Portland, OR.
  • Gille S; Kaiser Permanente Center for Health Research, Portland, OR.
  • Pawloski PA; Kaiser Permanente Center for Health Research, Portland, OR.
  • Liang SY; HealthPartners Institute, Bloomington, MN.
  • Schlieder V; Palo Alto Medical Foundation Research Institute, Palo Alto, CA.
  • Rahm AK; Department of Genomic Health, Geisinger, Danville, PA.
J Patient Cent Res Rev ; 9(4): 282-289, 2022.
Article em En | MEDLINE | ID: mdl-36340570
ABSTRACT

Purpose:

Genetic information has health implications for patients and their biological relatives. Death of a patient before sharing a genetic diagnosis with at-risk relatives is a missed opportunity to provide important information that could guide interventions to minimize cancer-related morbidity and mortality in relatives.

Methods:

We performed semi-structured interviews with individuals diagnosed with Lynch syndrome at 1 of 4 health systems to explore their perspectives on whether health systems should share genetic risk information with relatives following a patient's death. An inductive, open-coding approach was used to analyze audio-recorded content, with software-generated code reports undergoing iterative comparative analysis by a qualitative research team to identify broad themes and representative participant quotes.

Results:

Among 23 participating interviewees, 19 supported health systems informing relatives about their Lynch syndrome risk while the remaining 4 were conflicted about patient privacy. Most (n=22) wanted their Lynch syndrome diagnosis shared with relatives if they were unable to share and to be informed of their own risk if a diagnosed relative was unable to share. The most common issues noted regarding information-sharing with relatives included patient privacy and privacy laws (n=8), potential anxiety (n=5), and lack of contact information for relatives (n=3). Interviewee perspectives on how health systems could communicate genetic findings generated a consensus When - a few months after but within a year of the patient's death; How - explanatory letter and follow-up phone call; and Who - a knowledgeable professional.

Conclusions:

Interviews demonstrated strong and consistent perspectives from individuals diagnosed with Lynch syndrome that health systems have a role and responsibility to inform relatives of genetic findings following a patient's death.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Etiology_studies / Prognostic_studies / Qualitative_research / Risk_factors_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Etiology_studies / Prognostic_studies / Qualitative_research / Risk_factors_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article